Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
Eur J Surg Oncol
    April 2025
  1. PARK WK, Nam SJ, Kim SW, Yu J, et al
    Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of view.
    Eur J Surg Oncol. 2025;51:110011.
    >> Share

    March 2025
  2. ZHANG W
    Comment on "Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based study".
    Eur J Surg Oncol. 2025;51:110002.
    >> Share

  3. CHIA Z, O'Brien M, Shortland J, Holmes HM, et al
    The influence of physical post-operative rehabilitation interventions to improve upper limb strength in women undergoing breast cancer surgery: A Systematic Review of the literature.
    Eur J Surg Oncol. 2025;51:109983.
    >> Share

  4. CASELLA D, Rocco N, Sordi S, Catanuto G, et al
    The LyBra score: A risk assessment tool to address targeted prevention against breast cancer - Related lymphedema.
    Eur J Surg Oncol. 2025;51:109754.
    >> Share

  5. CORSI F, Cabri GF, Albasini S, Bossi D, et al
    Management of B3 breast lesions: Potential clinical implications from a retrospective study conducted in an accredited Breast Unit following the 2024 EUSOMA guidelines.
    Eur J Surg Oncol. 2025;51:109579.
    >> Share

  6. HYLDEBRANDT HK, Stormorken AT, Vitelli V, Maehle L, et al
    Risk reducing mastectomy in Norwegian BRCA1/2 carriers.
    Eur J Surg Oncol. 2025;51:109571.
    >> Share

  7. LEROY E, Poirier L, Planque H, Le Brun JF, et al
    Time to reconsider the use of synthetic mesh in immediate prepectoral implant-based breast reconstruction: Impact of their use on short-term outcomes.
    Eur J Surg Oncol. 2025;51:108780.
    >> Share

    February 2025
  8. LUCOCQ J, Baig H, McNeill E, Dixon JM, et al
    The efficacy and oncological safety of minimally invasive axillary procedures in patients with node-positive breast cancer receiving neoadjuvant chemotherapy: A network meta-regression and trial sequential analysis.
    Eur J Surg Oncol. 2025;51:109689.
    >> Share

  9. WOOLDRIK SM, Riks L, Struik GM, Hulsebosch F, et al
    Additional breast lesions on MRI in patients with small early stage luminal type breast cancer: Important consequences for future thermal ablation treatment.
    Eur J Surg Oncol. 2025;51:109715.
    >> Share

    January 2025
  10. CABIOGLU N, Karanlik H, Igci A, Uras C, et al
    Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study.
    Eur J Surg Oncol. 2025;51:109642.
    >> Share

  11. CATANUTO G, Gentile D, Martorana F, Tomatis M, et al
    Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database.
    Eur J Surg Oncol. 2025;51:109643.
    >> Share

  12. FU M, Peng Z, Wu M, Lv D, et al
    Assessing the African burden of breast cancer: A demographic analysis using Global Cancer Observatory 2022.
    Eur J Surg Oncol. 2025;51:109627.
    >> Share

  13. KUO WL, Huang JJ, Chu CH, Chang SC, et al
    Comparative analysis of oncological and surgical outcomes of robotic versus conventional mastectomy for breast cancer.
    Eur J Surg Oncol. 2025;51:109622.
    >> Share

  14. GORDON AB, Sheeka A, Cleator S, Leff D, et al
    Tumour volume analysis applied to imaging and histological examinations in breast cancer.
    Eur J Surg Oncol. 2025;51:109578.
    >> Share

  15. LIU X, Eriksson Bergman L, Boman C, Foukakis T, et al
    Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based study.
    Eur J Surg Oncol. 2025 Jan 7:109587. doi: 10.1016/j.ejso.2025.109587.
    >> Share

  16. T G, Sw K, S S, Gk R, et al
    Ethnicity and breast cancer incidence in over 329 500 women in England in 2011-2019.
    Eur J Surg Oncol. 2025 Jan 6:109585. doi: 10.1016/j.ejso.2025.109585.
    >> Share

  17. GATHANI T, Kan SW, Sweetland S, Reeves G, et al
    Ethnicity and breast cancer incidence in over 329,500 women in England in 2011-2019.
    Eur J Surg Oncol. 2025 Jan 6. doi: 10.1016/j.ejso.2025.109585.
    >> Share

  18. WONG AW, Sim NHS, Zhan SJ, Huang JJ, et al
    The efficacy of immediate lymphatic reconstruction after axillary lymph node dissection - A meta-analysis.
    Eur J Surg Oncol. 2025;51:109377.
    >> Share

  19. JAZRAWI A, Pantiora E, Abdsaleh S, Ng CL, et al
    Prospective evaluation of MRI artefacts following breast conserving surgery and sentinel lymph node dissection with the magnetic technique.
    Eur J Surg Oncol. 2025;51:109368.
    >> Share

  20. LUKAC S, Leinert E, Kuhn T, Dayan D, et al
    Eco-logistical comparison of non-radioactive seeds and the wire-guided localization for intraoperative detection of breast lesions.
    Eur J Surg Oncol. 2025;51:108779.
    >> Share

    December 2024
  21. VISWANATHAN D, Govindasamy R
    ERD-1233: A potent and orally active oestrogen receptor PROTAC degrader for treating ER+ breast cancer.
    Eur J Surg Oncol. 2024;51:109567.
    >> Share

  22. BOUZIANE J, Loap P, Cao K, Pauly L, et al
    Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approach.
    Eur J Surg Oncol. 2024;51:109555.
    >> Share

  23. GENNARO M, Mariani L, Palassini E, Stacchiotti S, et al
    Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimization.
    Eur J Surg Oncol. 2024;50:108699.
    >> Share

  24. MITCHELL MP, Shaitelman SF, Smith BD, Krishnamurthy S, et al
    Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy.
    Eur J Surg Oncol. 2024;50:108613.
    >> Share

    November 2024
  25. AIN Q, O'Connell RL, Swarnkar P, McVeigh T, et al
    Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation.
    Eur J Surg Oncol. 2024;51:109380.
    >> Share

  26. FTEROPOULLI T, Tzounaka E, Amirova A, Nikolopoulos G, et al
    Changes in health-related quality of life following breast cancer surgery: A systematic review of the literature on the role of surgical approaches.
    Eur J Surg Oncol. 2024 Nov 16:109467. doi: 10.1016/j.ejso.2024.109467.
    >> Share

  27. LAAS E, Dumas E, Hamy AS, Gaillard T, et al
    The influence of treatment intervals on prognosis in young breast cancer patients: Insights from the French National cohort.
    Eur J Surg Oncol. 2024;51:109373.
    >> Share

  28. PARK WK, Kim HJ, Ryu JM, Chae BJ, et al
    Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes.
    Eur J Surg Oncol. 2024;50:108644.
    >> Share

    October 2024
  29. ALLOTEY J, Ruparel V, McCallum A, Somal K, et al
    Residual microcalcifications after neoadjuvant systemic therapy for early breast cancer: Implications for surgical planning and long-term outcomes.
    Eur J Surg Oncol. 2024;51:108781.
    >> Share

  30. GENTILE D, Martorana F, Karakatsanis A, Caruso F, et al
    Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study.
    Eur J Surg Oncol. 2024;50:108732.
    >> Share

  31. JUNG SM, Kim YJ, Lee KT, Jeon BJ, et al
    Learning curve for robot-assisted nipple-sparing mastectomy: A single institution experience.
    Eur J Surg Oncol. 2024;50:108602.
    >> Share

  32. ALHUSSINI MA, Mohamed SM, Elfayoumi T, El-Damati AM, et al
    Goldilocks mastectomy; a modified technique enhancing the aesthetic outcome presented as a single center single-arm prospective cohort study.
    Eur J Surg Oncol. 2024;50:108586.
    >> Share

  33. ARISTOKLEOUS I, Pantiora E, Sjokvist O, Karakatsanis A, et al
    The value of patient-reported experience in oncoplastic breast conservation following standardized assessment and shared-decision making. A qualitative study.
    Eur J Surg Oncol. 2024;50:108524.
    >> Share

    September 2024
  34. LIU W, An J, Jiao C
    Reply to Letter to the Editor "the association between physical activity and risk for breast cancer in US female adults: A cross-sectional study based on NHANES 2011-2020".
    Eur J Surg Oncol. 2024;50:108709.
    >> Share

  35. ZHANG P, Guo M, Huang P
    Letter to the Editor "The association between physical activity and risk for breast cancer in US female adults: A cross-sectional study based on NHANES 2011-2020".
    Eur J Surg Oncol. 2024;50:108710.
    >> Share

  36. LONIE S, Crowley TP, Howitt R, Dildey P, et al
    Malignant phyllodes: 10 year review of management through a sarcoma service.
    Eur J Surg Oncol. 2024;50:108534.
    >> Share

  37. GIULIANI G, Vitale R, Brunetti N, Ninniri C, et al
    Non-palpable breast lesions localization techniques - A new priority: Results of a Senonetwork survey among breast centers in Italy.
    Eur J Surg Oncol. 2024;50:108471.
    >> Share

  38. HEIDINGER M, Loesch JM, Levy J, Maggi N, et al
    Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery - A retrospective cohort study.
    Eur J Surg Oncol. 2024;50:108478.
    >> Share

  39. SEN A, Jacob AT, Bhargavan R, Augustine P, et al
    Pre-chemotherapy clinically-guided skin tattooing + post-chemotherapy USG-guided skin marking: A time-tested, cost-effective technique for breast lesion localization, before Breast Conservation Surgery (BCS), in a high volume tertiary care cancer hosp
    Eur J Surg Oncol. 2024;50:108371.
    >> Share

  40. SARKAR DK
    Pre-chemotherapy clinically-guided skin tattooing + post-chemotherapy USG-guided skin marking: A time-tested, cost-effective technique for breast lesion localization, before Breast Conservation Surgery (BCS), in a high volume tertiary care cancer hosp
    Eur J Surg Oncol. 2024;50:108370.
    >> Share

    August 2024
  41. LIU W, An J, Jiao C, Zhi L, et al
    The Association Between Physical Activity and risk for breast cancer in US female adults: A cross-sectional study based on NHANES 2011-2020.
    Eur J Surg Oncol. 2024;50:108647.
    >> Share

  42. KAIDAR-PERSON O, Sklair-Levy M, Anaby D, Bernstein-Molho R, et al
    Residual breast tissue after mastectomy and reconstruction: A substudy of the Spatial location of breast cancer local rECurRence aftEr masTectomy (SECRET) project.
    Eur J Surg Oncol. 2024;50:108607.
    >> Share

  43. CABALLERO C, Lundon DJ, Vasileva-Slaveva M, Montagna G, et al
    A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.
    Eur J Surg Oncol. 2024;50:108585.
    >> Share

  44. DOWN S, Sandelin K, Wyld L, MacNeill F, et al
    Debate article: Management of breast cancer in patients with pre-existing bilateral breast augmentation-a snapshot of global practice and call for international guidelines.
    Eur J Surg Oncol. 2024;50:108606.
    >> Share

  45. CORTESI L, Cortesi G, Venturelli M, Marcheselli L, et al
    Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study.
    Eur J Surg Oncol. 2024;50:108603.
    >> Share

  46. JOHNSON MC, McGregor AH, A'Hern R, Leff DR, et al
    'I presumed the pain would eventually get better by itself'; challenges with access to rehabilitation for upper limb dysfunction after breast cancer treatment - Descriptive and qualitative findings from a cross-sectional survey.
    Eur J Surg Oncol. 2024;50:108591.
    >> Share

  47. RAKHA EA, Quinn C, Masannat YA, Lee AS, et al
    Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width.
    Eur J Surg Oncol. 2024;50:108573.
    >> Share

    July 2024
  48. JIANG M, Avery K, Ahmed R, de Boniface J, et al
    Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.
    Eur J Surg Oncol. 2024;50:108554.
    >> Share

  49. GEDFEW M, Getie A, Akalu TY, Ayenew T, et al
    Recurrence and associated factors of breast cancer among women in sub saharan africa, systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108528.
    >> Share

  50. GILL SS, Shukla A, Namireddy SR, Moin S, et al
    Exercise and recovery after surgery in patients with breast cancer: An analysis of the literature.
    Eur J Surg Oncol. 2024;50:108525.
    >> Share

  51. SCHIAVONE A, Ventimiglia F, Zarba Meli E, Taffurelli M, et al
    Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus.
    Eur J Surg Oncol. 2024;50:108351.
    >> Share

    June 2024
  52. SCHIPPER RJ, de Bruijn A, van der Sangen MJC, Bloemen JG, et al
    Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort study.
    Eur J Surg Oncol. 2024;50:108472.
    >> Share

  53. PLOUMEN RAW, Claassens EL, Kooreman LFS, Keymeulen KBMI, et al
    Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.
    Eur J Surg Oncol. 2024;50:108465.
    >> Share

  54. SPOOR J, Heeling E, Collewijn RC, van der Ploeg IMC, et al
    Intraoperative frozen section of subareolar tissue in nipple-sparing mastectomy: Towards a less is more approach.
    Eur J Surg Oncol. 2024;50:108320.
    >> Share

    May 2024
  55. YEO HAO XUAN M, Masuda Y
    Reply to: Surgery vs. non-surgery for liver metastases from primary breast cancer.
    Eur J Surg Oncol. 2024 May 29:108446. doi: 10.1016/j.ejso.2024.108446.
    >> Share

  56. HAN W, Shi CT, Wang HN
    Surgery vs. non-surgery for liver metastases from primary breast cancer.
    Eur J Surg Oncol. 2024 May 28:108445. doi: 10.1016/j.ejso.2024.108445.
    >> Share

  57. SAQIB HWU, Arshad HUA
    "Navigating breast cancer treatment: The role of early genetic testing".
    Eur J Surg Oncol. 2024;50:108392.
    >> Share

    April 2024
  58. SASADA S, Nagura N, Shimo A, Ogiya A, et al
    Impact of radiation therapy for breast cancer with involved surgical margin after immediate breast reconstruction: A multi-institutional observational study.
    Eur J Surg Oncol. 2024;50:108360.
    >> Share

  59. OGIYA A, Kimura K, Ueno T, Iwase T, et al
    Time trend of breast cancer-related lymphedema according to body mass index.
    Eur J Surg Oncol. 2024;50:108350.
    >> Share

  60. APOSTOLOVA C, Ferroum A, Alhassan B, Prakash I, et al
    Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.
    Eur J Surg Oncol. 2024;50:108324.
    >> Share

  61. NAVARRO AS, Omalek D, Chaltiel L, Vaysse C, et al
    Oncologic safety of autologous fat grafting in primary breast reconstruction after mastectomy for cancer.
    Eur J Surg Oncol. 2024;50:107998.
    >> Share

  62. MEATTINI I, Kunkler IH
    Omission of radiation therapy after breast conserving surgery for older women at low-risk of local recurrence: One option among many.
    Eur J Surg Oncol. 2024;50:108058.
    >> Share

  63. SAE-LIM C, Lai HW, Lin SL, Huang HI, et al
    Is minimal-accessed (endoscopic- or robotic-assisted) nipple-sparing mastectomy contraindicated for large breasts?
    Eur J Surg Oncol. 2024;50:108030.
    >> Share

    March 2024
  64. TASOULIS MK, Muktar S, Smith I, Roche N, et al
    Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy.
    Eur J Surg Oncol. 2024;50:108277.
    >> Share

  65. DI LENA E, Wong SM, Iny E, Mashal S, et al
    Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study.
    Eur J Surg Oncol. 2024;50:108266.
    >> Share

  66. LOVELAND-JONES C, Gaughan J, Caudle A, Murphy B, et al
    Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry.
    Eur J Surg Oncol. 2024;50:108245.
    >> Share

    February 2024
  67. SKJERVEN HK, Myklebust EM, Korvald C, Stubberud K, et al
    Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study.
    Eur J Surg Oncol. 2024;50:107938.
    >> Share

  68. VAN DAM MA, Bijlstra OD, Faber RA, Warmerdam MI, et al
    Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgery.
    Eur J Surg Oncol. 2024;50:107317.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016